Boundless Bio, Inc. is a clinical-stage biotechnology company based in San Francisco, California, dedicated to pioneering gene therapies targeted at rare, life-threatening diseases resulting from single gene defects. With a robust pipeline of innovative therapeutic candidates, the company is committed to fulfilling unmet medical needs through cutting-edge research and development. Positioned at the forefront of the gene therapy landscape, Boundless Bio aims to improve treatment outcomes and enhance the quality of life for patients, thereby significantly impacting healthcare and patient communities. Show more

Location: 10955 ALEXANDRIA WAY, SAN DIEGO, CA, UNITED STATES, 92121, San Diego, CA, 92121, USA | Website: https://boundlessbio.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

25.97M

52 Wk Range

$1.00 - $2.54

Previous Close

$1.18

Open

$1.16

Volume

122,302

Day Range

$1.13 - $1.17

Enterprise Value

-41.85M

Cash

14.98M

Avg Qtr Burn

-10.2M

Insider Ownership

11.40%

Institutional Own.

57.96%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
BBI-355 + BBI-825 Details Locally advanced or metastatic solid tumors with oncogene amplifications	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BBI-940 Details Indication unknown (ecDNA segregation and inheritance)	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.